Company Information & Drug Savings for Vivus LLC Medications

VIVUS LLC is a specialty biopharmaceutical company headquartered in Campbell, California, focused on the development and commercialisation of innovative therapies for serious and life-limiting conditions. Founded in 1991 and now a subsidiary of Icahn Enterprises LP, VIVUS markets three FDA-approved products in the US: Qsymia® (phentermine/topiramate extended-release) for chronic weight management; PANCREAZE® (pancrelipase) for exocrine pancreatic insufficiency due to cystic fibrosis and other conditions; and STENDRA® (avanafil) for erectile dysfunction. The company combines clinical development expertise with a dedicated specialty sales force to address unmet medical needs across obesity, endocrinology, and urology.